pharma · Irritable Bowel Syndrome With Constipation · Chronic Constipation · IRWD
IRONWOOD PHARMACEUTICALS
IRONWOOD PHARMACEUTICALS INC
IRONWOOD PHARMACEUTICALS is a pharma organization headquartered in Boston, USA. It trades on NYSE under ticker IRWD. Primary therapeutic focus areas include Irritable Bowel Syndrome With Constipation, Chronic Constipatio
100 Summer Street, Boston, MA 02110, US HQ
1998 Founded
262 Employees
Public company Type
IRWD · NYSE Ticker
Company details
- Status
- Public
- HQ
- 100 Summer Street, Boston, MA 02110, US
- Founded
- 1998
- Employees
- 262
- Programs
- 33
- Drugs
- 11
- Patents
- 45
IW-3718
Phase 3 · small molecule · Gastroesophageal Reflux Disease (GERD)
IW-3718 for Gastroesophageal Reflux Disease (GERD) is a Phase 3 program (small_molecule) at IRONWOOD PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Internal code C3718-301
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- IRONWOOD PHARMACEUTICALS INC
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Gastroesophageal Reflux Disease (GERD)
- Status
- terminated
- Trials
- 2